24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Equashield
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:36
“Israeli founders, even with reserve duty disruptions, managed to outperform expectations”
09:56
Here’s how PhaseV uses AI to optimize clinical trials to speed clinical development
09:52
“We will see a lot of mid-sized mid-market companies evaporate in the coming years”
09:49
Cyera CEO: “We allow enterprises to move quickly with AI but to do it responsibly and securely”
More stories
Buzz
Most popular
Daily
Weekly
1
"We saved $350 million last year using AI agents"
2
“Bigger than Wiz”: Sequoia’s Shaun Maguire says Israel can build trillion-dollar companies
3
The top 10 Israeli startups to watch out for in 2025
4
Cyber startup Island raises $250 million at $4.8 billion valuation
5
A new Wiz? Roi Tiger’s secretive cyber startup raising $55M at sky-high valuation
More news
Equashield
1 stories about Equashield
Biotech company Equashield sells 25% stake to Nordic Capital at $1.3 billion valuation
06.10.22
|
Golan Hazani
CEO and co-founder Eric Shem-Tov is the largest shareholder at the company, which has registered sales in the hundreds of millions of dollars to hospitals across the world for its manual and automated solutions for the compounding and administration of hazardous drugs